Latest Orphan drug Stories
US Orphan Designation Granted for MI-100 in June 2014, by Food and Drug Administration (FDA) DOYLESTOWN, Pa., May 4, 2015 /PRNewswire/ -- Makindus, Inc.
GENEVA, May 4, 2015 /PRNewswire/ -- EspeRare today announced that the European Medicines Agency (EMA) has granted an Orphan Drug Designation (ODD) for rimeporide, its lead
REHOVOT, Israel and NEW YORK, May 1, 2015 /PRNewswire/ -- Advanced Inhalation Therapies Ltd (AIT), a leading anti-microbial therapeutic company, announced that the European
GIA announces the release of a comprehensive global report on Orphan Drugs.
-- Cantrixil receives Orphan Drug Designation in U.S.
MARLBOROUGH, Mass., April 17, 2015 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies
CALGARY, April 17, 2015 /PRNewswire/ - Oncolytics Biotech Inc.
CORAL SPRINGS, Florida, April 9, 2015 /PRNewswire/ -- According to a recent article [http://blogs.wsj.com/pharmalot/2014/09/29/high-prices-for-orphan-drug-can-be-sustained-a-payer-survey-shows
Novel Product Focused On Treatment of Comorbidities of Sickle Cell Disease SOUTH PLAINFIELD, N.J., April 8, 2015 /PRNewswire/ -- Prolong Pharmaceuticals, LLC, a biopharmaceutical company
A company that produces a cancer vaccine called CRS-207 has been granted orphan drug status for the treatment of malignant mesothelioma, potentially opening new treatment possibilities for patients
- an ornament or knob in the shape of a flower